Insider · CIK 0001208541
Mark S Ordan
Files at MD (Pediatrix Medical Group, Inc.), CG (Carlyle Group Inc.). First filing Nov 14, 2024, latest Dec 17, 2025.
Mark S Ordan files SEC Form 4 as director and CEO at MD (Pediatrix Medical Group, Inc.), and also at CG (Carlyle Group Inc.). Since Nov 14, 2024, Mark S Ordan has reported 0 open-market buys worth $0 and 2 open-market sells worth $939k, the latest filed on Dec 17, 2025.
A track record needs three past buys with six months of prices behind them; Mark S Ordan has 0, so none is measured yet.
The newest scored trade: sold $515k of MD on Dec 15, 2025, filed Dec 17, 2025, scored 43 (moderate). In the last 12 months: 0 buys worth $0 and 1 sell worth $515k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MD: Pediatrix Medical Group, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 43Moderate | MDsell Pediatrix Medical Group, Inc. | $515k 23,000 shares | -7% | +89% from low-8% from high | |
| 44Moderate | Pediatrix Medical Group, Inc. | $424k 27,600 shares | -17% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Dec 15, 2025 | MD Pediatrix Medical Group, Inc. | 23,000 0.03% of outstanding | $518k | Dec 15, 2025 | none |
| Nov 13, 2024 | MD Pediatrix Medical Group, Inc. | 27,600 0.03% of outstanding | $428k | Nov 13, 2024 | none |
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 1, 2026 | CG Carlyle Group Inc. | AGrant or award Common Stock | +4,450 | $0.00 | $0 | 26,163 | May 1, 2026 |
| May 1, 2026 | CG Carlyle Group Inc. | AGrant or award Common Stock | +4,450 | $49.44 | $220k | 30,613 | May 1, 2026 |
| Dec 15, 2025 | MD Pediatrix Medical Group, Inc. | SOpen-market sale Common Stock | -23,000 | $22.41 | $515k | 302,805 | Dec 17, 2025 |
| Jun 1, 2025 | MD Pediatrix Medical Group, Inc. | AGrant or award Common Stock | +194,347 | $0.00 | $0 | 325,805 | Jun 3, 2025 |
| May 9, 2025 | MD Pediatrix Medical Group, Inc. | FTax withholding Common Stock | -7,225 | $14.44 | $104k | 131,458 | May 12, 2025 |
| May 1, 2025 | CG Carlyle Group Inc. | AGrant or award Common Stock | +5,235 | $0.00 | $0 | 21,713 | May 2, 2025 |
| Nov 13, 2024 | MD Pediatrix Medical Group, Inc. | SOpen-market sale Common Stock | -27,600 | $15.35 | $424k | 138,683 | Nov 14, 2024 |
Questions about Mark S Ordan
Answered from the filings on this page, as of the latest one.
Is Mark S Ordan buying or selling?
In the last 12 months Mark S Ordan reported 0 open-market buys worth $0 and 1 open-market sell worth $515k on SEC Form 4; the latest was sold $515k of MD on Dec 15, 2025. Grants, option exercises and tax withholding are not counted.
How did Mark S Ordan's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Mark S Ordan has 0.
Where does Mark S Ordan file Form 4?
Mark S Ordan has filed Form 4 at MD (Pediatrix Medical Group, Inc.) as Chief Executive Officer; CG (Carlyle Group Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.